Your browser doesn't support javascript.
loading
Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.
Yagyu, Hiroaki; Okada, Kenta; Sato, Shin; Yamashita, Yumiko; Okada, Nobukazu; Osuga, Jun-Ichi; Nagasaka, Shoichiro; Sugano, Kentaro; Ishibashi, Shun.
Afiliação
  • Yagyu H; Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, Japan. hiroakiyagyu@aol.com
Diabetes Res Clin Pract ; 95(3): e52-4, 2012 Mar.
Article em En | MEDLINE | ID: mdl-22154462
ABSTRACT
The combination of pegylated interferon-α2b (PEG-IFNα) and ribavirin (RBV) is a standard treatment for chronic hepatitis C. The case of a patient with chronic hepatitis C who developed Hashitoxicosis followed by type 1 diabetes mellitus (T1DM) with PEG-IFNα plus RBV combination therapy, but not IFNα alone, is presented.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Ribavirina / Interferon-alfa / Hepatite C Crônica / Diabetes Mellitus Tipo 1 / Doença de Hashimoto Tipo de estudo: Etiology_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Ribavirina / Interferon-alfa / Hepatite C Crônica / Diabetes Mellitus Tipo 1 / Doença de Hashimoto Tipo de estudo: Etiology_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Diabetes Res Clin Pract Ano de publicação: 2012 Tipo de documento: Article